Suppr超能文献

头颈部癌放疗等待时间中的肿瘤进展

Tumor progression in waiting time for radiotherapy in head and neck cancer.

作者信息

Jensen Anni Ravnsbaek, Nellemann Hanne Marie, Overgaard Jens

机构信息

Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, Building 5, DK-8000 Aarhus C, Denmark.

出版信息

Radiother Oncol. 2007 Jul;84(1):5-10. doi: 10.1016/j.radonc.2007.04.001. Epub 2007 May 9.

Abstract

INTRODUCTION

Waiting-time prior to radiotherapy is a well-known problem. This study aims to determine the impact of time on tumor growth in a patient population with squamous-cell carcinoma of the head and neck (SCCHN).

MATERIAL AND METHODS

In a consecutive cohort, all patients with both a diagnostic scan and a treatment-planning scan were identified. In total 648 patients were seen, and 414 treated with primary radiotherapy. Ninety-five had two scans and 61 sets were eligible for comparison. Endpoints were change in tumor volume, tumor volume doubling time (TVD) and disease progression measured by TNM-classification and RECIST criteria.

RESULTS

Median interval between eligible scans was 28 (5-95) days. Thirty-eight (62%) had measurable increase in tumor volume, median 46% (6-495%). For all patients TVD was median 99 days, but for the half of patients with fastest growing tumors TVD was 30 days (15-41). Tumor volume increase was significantly correlated to time and histological differentiation. Twelve (20%) developed new lymph-node metastasis and 10 (16%) progressed in TNM-classification. Evaluated by RECIST criteria 18 (30%) patients had progressive disease.

INTERPRETATION

This study shows a negative impact of waiting time in patients with SCCHN. Within an average time of 4 weeks the majority of the patients developed significant signs of tumor progression. It was not possible to define a threshold for acceptable time intervals in order to avoid volume changes, or to define a subgroup that has no negative impact of delay.

摘要

引言

放疗前的等待时间是一个众所周知的问题。本研究旨在确定时间对头颈鳞状细胞癌(SCCHN)患者群体中肿瘤生长的影响。

材料与方法

在一个连续队列中,识别出所有同时进行了诊断扫描和治疗计划扫描的患者。总共观察了648例患者,其中414例接受了原发性放疗。95例患者有两次扫描,61组符合比较条件。终点指标包括肿瘤体积变化、肿瘤体积倍增时间(TVD)以及通过TNM分类和RECIST标准衡量的疾病进展。

结果

符合条件的扫描之间的中位间隔时间为28(5 - 95)天。38例(62%)患者的肿瘤体积有可测量的增加,中位增加46%(6 - 495%)。所有患者的TVD中位值为99天,但对于肿瘤生长最快的一半患者,TVD为30天(15 - 41)。肿瘤体积增加与时间和组织学分化显著相关。12例(20%)出现了新的淋巴结转移,10例(16%)在TNM分类中病情进展。根据RECIST标准评估,18例(30%)患者出现疾病进展。

解读

本研究表明等待时间对SCCHN患者有负面影响。在平均4周的时间内,大多数患者出现了肿瘤进展的明显迹象。无法确定一个可接受的时间间隔阈值以避免体积变化,也无法确定一个不受延迟负面影响的亚组。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验